Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Rubin Gary D. Officer active across 1 company, notably bioAffinity Technologies, Inc.. Cumulatively, 5 disclosures have been logged. Activity tracked since 6 September 2022. The latest transaction was filed on 1 July 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Rubin Gary D is a Director of bioAffinity Technologies, Inc. (XNAS). He has 5 filings in total, and across the 5 recent filings tracked, the attribution amounts run from 2022-10-21 to 2024-07-02.